{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:40:28Z","timestamp":1788892828972,"version":"build-2803163510"},"reference-count":37,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Aims: The aim of this study was to assess the prevalence of anemia and iron deficiency in patients with heart failure with preserved ejection fraction (HFpEF) and its impact on clinical outcomes. Methods: We retrospectively analyzed 212 patients with HFpEF and identified anemia as a serum hemoglobin level of less than 13 g\/dL in men and less than 12 g\/dL in women. Additionally, ID was defined as a serum ferritin concentration &lt; 100 ng\/mL or 100\u2013299 ng\/mL with transferrin saturation &lt; 20%. Patients were followed up for an average of 66.2 \u00b1 12.1 months, with the endpoint being all-cause mortality among patients with HFpEF, both with and without anemia and iron deficiency. Furthermore, we explored other predictors of all-cause mortality. Results: The average age of the entire group was 70.6 \u00b1 10.5 years, with females comprising 55% of the patients. Anemia was present in 81 (38.2%) patients, while 108 (50.9%) had iron deficiency. At the end of the follow-up period, 60 (28.3%) of the patients had passed away. Patients with anemia displayed more heart failure (HF) symptoms, diastolic dysfunction, higher NT-pro-BNP levels, and worse baseline functional capacity than those without. Similarly, patients with iron deficiency showed more pronounced HF symptoms and worse functional capacity than those without. The results from the multivariable analyses revealed that anemia (hazard ratio [HR]: 5.401, 95% confidence interval [CI]: 4.303\u20136.209, log-rank p = 0.001), advanced age, iron deficiency (HR: 3.502, 95% CI: 2.204\u20136.701, log-rank p = 0.015), decreased left ventricular ejection fraction, chronic kidney disease, and paroxysmal nocturnal dyspnea were all independently associated with all-cause mortality. Conclusions: It is essential to consider anemia and iron deficiency as common comorbidities in managing and prognosis HFpEF, as they significantly increase mortality risk.<\/jats:p>","DOI":"10.3390\/diagnostics14020209","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T06:41:22Z","timestamp":1705560082000},"page":"209","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Anemia and Iron Deficiency Predict All-Cause Mortality in Patients with Heart Failure and Preserved Ejection Fraction: 6-Year Follow-Up Study"],"prefix":"10.3390","volume":"14","author":[{"given":"Fato\u015f Dilan","family":"K\u00f6seo\u011flu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology, Faculty of Medicine, Bakircay University, 35665 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fclent","family":"\u00d6zlek","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Mugla Sitki Kocman University, 48000 Mugla, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.15420\/cfr.2022.06","article-title":"Epidemiology and Clinical Features of Heart Failure with Preserved Ejection Fraction","volume":"8","author":"Teramoto","year":"2022","journal-title":"Card. Fail. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/164_2017_27","article-title":"Comorbidities in Heart Failure","volume":"243","author":"Voors","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0140-6736(07)61235-5","article-title":"Nutritional iron deficiency","volume":"370","author":"Zimmermann","year":"2007","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/eurheartj\/ehac569","article-title":"Iron deficiency and cardiovascular disease","volume":"44","author":"Savarese","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2171885","DOI":"10.1080\/0886022X.2023.2171885","article-title":"Is serum hemoglobin level an independent prognostic factor for IgA nephropathy?: A systematic review and meta-analysis of observational cohort studies","volume":"45","author":"Zhang","year":"2023","journal-title":"Ren. Fail."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ueg2.12420","article-title":"How many biomarker measurements are needed to predict prognosis in Crohn\u2019s disease patients under infliximab?-A prospective study","volume":"11","author":"Magro","year":"2023","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e000759","DOI":"10.1136\/bmjgast-2021-000759","article-title":"Iron deficiency anaemia: Pathophysiology, assessment, practical management","volume":"9","author":"Kumar","year":"2022","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12957-021-02452-7","article-title":"Anemia can predict the prognosis of colorectal cancer in the pre-operative stage: A retrospective analysis","volume":"19","author":"Gvirtzman","year":"2021","journal-title":"World J. Surg. Oncol."},{"key":"ref_10","unstructured":"World Health Organization (1968). Nutritional anemias, Report of a WHO Scientific Group, WHO Techn. Rep. Ser., 405, 9\u201310."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jchf.2016.02.017","article-title":"Precipitating Clinical Factors, Heart Failure Characterization, and Outcomes in Patients Hospitalized With Heart Failure With Reduced, Borderline, and Preserved Ejection Fraction","volume":"4","author":"Kapoor","year":"2016","journal-title":"JACC Heart Fail."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ejhf.945","article-title":"A comprehensive population-based characterization of heart failure with mid-range ejection fraction","volume":"19","author":"Koh","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJMe2309294","article-title":"Heart Failure with Preserved Ejection Fraction\u2014A Metabolic Disease?","volume":"389","author":"Pinto","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e1916598","DOI":"10.1001\/jamanetworkopen.2019.16598","article-title":"Association of \u03b2-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT Trial","volume":"2","author":"Silverman","year":"2019","journal-title":"JAMA Netw. Open."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1136\/heartjnl-2022-322145","article-title":"Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease","volume":"109","author":"Graham","year":"2023","journal-title":"Heart"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","article-title":"Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction","volume":"64","author":"Mentz","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ni, T., Liu, Y., Huang, M., Ma, M., Li, L., Li, C., Yang, R., and Yu, C. (2023). Association Between Anemia Status and the Risk of Different Types of Heart Failure: A RCSCD-TCM Study in China. Angiology, 33197231161908. Online ahead of print.","DOI":"10.1177\/00033197231161908"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.amjcard.2020.01.046","article-title":"Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial)","volume":"125","author":"Gupta","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijcard.2019.08.049","article-title":"Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum","volume":"298","author":"Savarese","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ihj.2021.06.011","article-title":"Prognostic role of anemia in heart failure with preserved ejection fraction: A systematic review and meta-analysis","volume":"73","author":"Majmundar","year":"2021","journal-title":"Indian. Heart J."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Pint\u00e9r, A., Behon, A., Veres, B., Merkel, E.D., Schwertner, W.R., Kuthi, L.K., Masszi, R., Lakatos, B.K., Kov\u00e1cs, A., and Becker, D. (2022). The Prognostic Value of Anemia in Patients with Preserved, Mildly Reduced and Recovered Ejection Fraction. Diagnostics, 12.","DOI":"10.3390\/diagnostics12020517"},{"key":"ref_26","first-page":"100597","article-title":"Relationship of anemia and clinical outcome in heart failure patients with preserved versus reduced ejection fraction in a rural area of Thailand","volume":"30","author":"Chairat","year":"2020","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ehf2.14302","article-title":"Long-term outcomes in heart failure with preserved ejection fraction: Predictors of cardiac and non-cardiac mortality","volume":"10","author":"Shahim","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_28","first-page":"101255","article-title":"Contributions of anemia to exercise intolerance in heart failure with preserved ejection fraction-An exercise stress echocardiographic study","volume":"48","author":"Naito","year":"2023","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/oxfordjournals.ndt.a027970","article-title":"Pathophysiology of anaemia: Focus on the heart and blood vessels","volume":"15","author":"Metivier","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/ehf2.12797","article-title":"Anaemia, iron deficiency and heart failure in 2020: Facts and numbers","volume":"7","author":"Chopra","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ejhf.139","article-title":"High prevalence of iron deficiency in patients with acute decompensated heart failure","volume":"16","author":"Damy","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00392-018-1344-x","article-title":"Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life","volume":"108","author":"Bekfani","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Alcaide-Aldeano, A., Garay, A., Alcoberro, L., Jim\u00e9nez-Marrero, S., Yun, S., Tajes, M., Garc\u00eda-Romero, E., D\u00edez-L\u00f3pez, C., Gonz\u00e1lez-Costello, J., and Mateus-Porta, G. (2020). Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041199"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e001012","DOI":"10.1136\/openhrt-2019-001012","article-title":"Iron deficiency in heart failure with preserved ejection fraction: A systematic review and meta-analysis","volume":"6","author":"Beale","year":"2019","journal-title":"Open Heart"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/ehf2.13204","article-title":"Iron deficiency impacts prognosis but less exercise capacity in heart failure with preserved ejection fraction","volume":"8","author":"Henkens","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1002\/ehf2.13617","article-title":"Impact of change in iron status over time on clinical outcomes in heart failure according to ejection fraction phenotype","volume":"8","author":"Fitzsimons","year":"2021","journal-title":"ESC Heart Fail."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/2\/209\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:49:43Z","timestamp":1760104183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/2\/209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["diagnostics14020209"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14020209","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]}}}